DEVELOPMENT OF A SET OF EBV -SPECIFIC ANTIGENS WITH RECOMBINANT GENE TECHNOLOGY FOR DIAGNOSIS OF EBV-RELATED MALIGNANT OR NONMALIGNANT DISEASES